entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 09:45:18 - browse：4373

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： The high personal cost of affirmative action for Black doctors

WSS

Mass General, Mayo Clinic look to monetize custom

Printout prescription drug information shouldn’t go digital

What to expect as Trump is arraigned on his Jan 6. indictment

Amazon expands telehealth clinic nationwide

EQRx, failed developer of low

Future doctors need a strong humanities education

focus

entertainment

hotspot

Activists slam private health insurers over coverage restrictions

Pumping milk in bathrooms at health conferences is common

The cancer drug shortage isn’t new — and neither are the solutions

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

ChatGPT in medicine: STAT answers readers' burning questions

Medicare bonuses could stop drug shortages under Senate plan

Cancer drug shortages should be causing more outrage

To bolster infectious disease surveillance, genomics powerhouses team up

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Dog Aging Project founders on what lies ahead after losing funding

focus

High breast density mammograms need follow

FDA endorses new sterilization method for medical devices

Future doctors need a strong humanities education

What causes osteoarthritis? Researchers study link to brain protein

Mass General, Mayo Clinic look to monetize custom

Mass General, Mayo Clinic look to monetize custom

hotspot

hotspot

leisure time

focus